GEn1E Lifesciences
Clinical-stage, Phase 2 biopharmaceutical company accelerating 1st-in-class precision therapies for inflammatory and rare diseases.
- Founded
- 2018
- Headquarters
- San Francisco
- Company size
- Not disclosed
- Products tracked
- 1
Products by GEn1E Lifesciences
Pricing for GEn1E Lifesciences
Contact sales
Contact GEn1E Lifesciences for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
No compliance claims have been published for this company.